BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 402384)

  • 1. Immunoreactivity and serum destruction of N3immethyl-trh.
    Dvorak JC; Utiger RD
    J Clin Endocrinol Metab; 1977 Mar; 44(3):582-5. PubMed ID: 402384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma clearance and plasma half-disappearance time of exogenous thyrotropin-releasing hormone and pyroglutamyl-N3im-methyl-histidyl prolineamide.
    Morley JE; Garvin TJ; Pekary AE; Utiger RD; Nair MG; Baugh CM; Hershman JM
    J Clin Endocrinol Metab; 1979 Mar; 48(3):377-80. PubMed ID: 107180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the transport of thyrotropin-releasing hormone (TRH) analogues in Caco-2 cell monolayers.
    Urayama A; Yamada S; Deguchi Y; Ohmori Y; Kimura R
    J Pharm Pharmacol; 2003 May; 55(5):603-8. PubMed ID: 12831502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of degradation and measurement of immunoreactive thyrotropin-releasing hormone in rat blood and plasma.
    Eskay RL; Oliver C; Warberg J; Porter JC
    Endocrinology; 1976 Feb; 98(2):269-77. PubMed ID: 813988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors.
    Klootwijk W; de Herder WW; Kwekkeboom DJ; Lamberts SW; Krenning EP; Visser TJ; de Greef WJ
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2816-20. PubMed ID: 8768836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of 3H-[3-M3-His2]TRH as an improved ligand for TRH receptors.
    Taylor RL; Burt DR
    Neuroendocrinology; 1981 May; 32(5):310-6. PubMed ID: 6264336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solubilization of receptors for thyrotropin-releasing hormone from GH4C1 rat pituitary cells: demonstration of guanyl nucleotide sensitivity.
    Sullivan NJ; Lautens LL; Tashjian AH
    Mol Endocrinol; 1987 Dec; 1(12):889-98. PubMed ID: 2856405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans.
    Klootwijk W; Sleddens-Linkels E; de Boer R; Jansen CA; Autar R; de Herder WW; Boevé ER; Visser TJ; de Greef WJ
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3068-73. PubMed ID: 9284745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anti-thyrotropin-releasing hormone anti-serum treatment during the neonatal period on the development of rat thyroid function.
    Mitsuma T; Nogimori T
    Horm Metab Res; 1984 Aug; 16(8):428-30. PubMed ID: 6432670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of prolactin and thyrotropin secretion in the rat by antiserum to thyrotropin-releasing hormone.
    Koch Y; Goldhaber G; Fireman I; Zor U; Shani J; Tal E
    Endocrinology; 1977 May; 100(5):1476-8. PubMed ID: 403069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamyl-N3im-methyl-histidyl-prolineamide (methyl-thyrotrophin releasing hormone) in the rat hypothalamus.
    Pekary AE; Morley JE; Hershman JM
    J Endocrinol; 1978 Jun; 77(3):405-8. PubMed ID: 96203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyrotropin-releasing hormone receptors in the pituitary of rainbow trout (Oncorhynchus mykiss).
    Schwartzentruber RS; Omeljaniuk RJ
    Gen Comp Endocrinol; 1995 Feb; 97(2):209-19. PubMed ID: 7622016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts toward biosynthesis of the thyrotropin-releasing hormone and studies on its breakdown in hypothalamic tissue preparations.
    Bauer K; Lipmann F
    Endocrinology; 1976 Jul; 99(1):230-42. PubMed ID: 820546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lower levels of thyrotropin-releasing hormone-degrading activity in human cord and in maternal sera than in the serum of euthyroid, nonpregnant adults.
    Neary JT; Nakamura C; Davies IJ; Soodak M; Maloof F
    J Clin Invest; 1978 Jul; 62(1):1-5. PubMed ID: 96140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRH-like immunoreactivity in urine, serum and extrahypothalamic brain: non-identity with synthetic pyroglu-hist-pro-NH2 (TRH).
    Youngblood WW; Lipton MA; Kizer JS
    Brain Res; 1978 Jul; 151(1):99-116. PubMed ID: 98209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of evidence for thyrotropin-releasing hormone deamidation in normal and hyperthyroid human sera.
    Emerson CH; Mishal A; Mahabeer HL; Currie BL
    J Clin Endocrinol Metab; 1979 Jul; 49(1):138-40. PubMed ID: 109463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic immunization of endogenous thyrotrophin-releasing hormone (TRH) in brain alters the behavioural response to pentobarbital and a TRH analogue.
    Lighton C; Bennett GW; Marsden CA
    Brain Res; 1986 Jul; 378(2):385-9. PubMed ID: 3089541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physiological role of thyrotropin-releasing hormone in the regulation of thyroid-stimulating hormone and prolactin secretion in the rat.
    Harris AR; Christianson D; Smith MS; Fang SL; Braverman LE; Vagenakis AG
    J Clin Invest; 1978 Feb; 61(2):441-8. PubMed ID: 413840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A radioimmunoassay for the measurement of pyroglutamyl-histidyl-proline, a proposed thyrotropin releasing hormone metabolite.
    Visser TJ; Klootwijk W; Docter R; Hennemann G
    J Clin Endocrinol Metab; 1975 Apr; 40(4):742-5. PubMed ID: 805158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRH immunoreactivity in human urine: evidence for dissociation from TRH.
    Emerson CH; Frohman LA; Szabo M; Thakkar I
    J Clin Endocrinol Metab; 1977 Sep; 45(3):392-9. PubMed ID: 409725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.